Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001723485-17-000002
Filing Date
2017-11-27
Accepted
2017-11-27 11:57:16
Documents
1
Effectiveness Date
2017-11-27
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5770
  Complete submission text file 0001723485-17-000002.txt   6812
Mailing Address 1301 EAST 9TH STREET, SUITE 3700 CLEVELAND OH 44114
Business Address 1301 EAST 9TH STREET, SUITE 3700 CLEVELAND OH 44114 216-912-0567
Ohio Therapeutics, LLC (Filer) CIK: 0001723485 (see all company filings)

EIN.: 821446433 | State of Incorp.: OH | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-299476 | Film No.: 171222220